DexCom, Inc. (DXCM) PS Ratio: 6.18
Is DexCom, Inc.’s P/S ratio high or low?
DexCom, Inc.'s P/S ratio of 6.18 is 54% below its 5-year average of 13.46, near the low end of its 5-year range (4.72–30.21).
The P/S ratio for DexCom, Inc. (DXCM) is 6.18 as of Wednesday, June 10, 2026. It is below its 12-month average by 3.90% (6.43).
DXCM PS Ratio Chart
DXCM Average PS Ratio Chart
DXCM Current vs Average PS Ratio Chart
DXCM PS Ratio Metrics
PS RATIO
6.18
PS RATIO AVG TTM
6.43
PS RATIO AVG 3Y
9.81
PS RATIO AVG 5Y
13.46
PS RATIO AVG 10Y
13.68
PS RATIO AVG 15Y
14.08
PS RATIO AVG 20Y
153.99
CURRENT VS TTM AVG
-3.90%
CURRENT VS 3Y AVG
-36.97%
CURRENT VS 5Y AVG
-54.07%
CURRENT VS 10Y AVG
-54.82%
CURRENT VS 15Y AVG
-56.10%
CURRENT VS 20Y AVG
-95.99%
DXCM Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DexCom, Inc. (DXCM) | — | 6.18 | 6.43 | 9.81 | 13.46 |
| Biogen Inc. (BIIB) | $29.00B | 2.96 | 2.43 | 2.85 | 3.13 |
| IQVIA Holdings Inc. (IQV) | $30.60B | 1.87 | 2.07 | 2.42 | 2.72 |
| Veeva Systems Inc. (VEEV) | $26.73B | 8.19 | 13.05 | 13.76 | 16.18 |
| Centene Corporation (CNC) | $31.94B | 0.16 | 0.11 | 0.19 | 0.25 |
| Zoetis Inc. (ZTS) | $34.20B | 3.62 | 6.10 | 8.19 | 9.35 |
| Waters Corporation (WAT) | $23.83B | 7.97 | 6.60 | 6.58 | 6.83 |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 5.61 | 6.80 | 6.98 | 7.67 |
| BioNTech SE (BNTX) | $21.81B | 6.64 | 7.56 | 6.75 | 5.47 |
| Agilent Technologies, Inc. (A) | $37.17B | 5.17 | 5.30 | 5.53 | 5.97 |
P/S vs. its own history
At 6.18, P/S is cheaper than usual — richer than 3% of its 20-year range.
20-year low
4.72
median
15.48
20-year high
29128.47
Sales Valuation
P/S Ratio
6.18
Market Cap / Annual Revenue
DexCom, Inc. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
DexCom, Inc. PS Ratio FAQ
- What is the P/S ratio for DexCom, Inc. (DXCM)?
- The P/S ratio for DXCM stock is 6.18.
- Is DexCom, Inc.'s P/S ratio high or low?
- DexCom, Inc.'s P/S ratio of 6.18 is 54% below its 5-year average of 13.46, near the low end of its 5-year range (4.72–30.21).
- What is the TTM average P/S ratio for DexCom, Inc. (DXCM)?
- The TTM average P/S ratio for DXCM stock is 6.43.
- What is the 3Y average P/S ratio for DexCom, Inc. (DXCM)?
- The 3Y average P/S ratio for DXCM stock is 9.81.
- What is the 5Y average P/S ratio for DexCom, Inc. (DXCM)?
- The 5Y average P/S ratio for DXCM stock is 13.46.
- What is the 10Y average P/S ratio for DexCom, Inc. (DXCM)?
- The 10Y average P/S ratio for DXCM stock is 13.68.
- What is the 15Y average P/S ratio for DexCom, Inc. (DXCM)?
- The 15Y average P/S ratio for DXCM stock is 14.08.
- What is the 20Y average P/S ratio for DexCom, Inc. (DXCM)?
- The 20Y average P/S ratio for DXCM stock is 153.99.
DexCom, Inc. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-10 | 6.18 |
| 2026-06-09 | 6.39 |
| 2026-06-08 | 6.26 |
| 2026-06-05 | 5.95 |
| 2026-06-04 | 5.93 |
| 2026-06-03 | 5.94 |
| 2026-06-02 | 6.00 |
| 2026-06-01 | 6.12 |
| 2026-05-29 | 6.02 |
| 2026-05-28 | 5.91 |
| 2026-05-27 | 5.74 |
| 2026-05-26 | 5.88 |
| 2026-05-22 | 5.89 |
| 2026-05-21 | 5.87 |
| 2026-05-20 | 5.84 |
| 2026-05-19 | 5.47 |
| 2026-05-18 | 5.32 |
| 2026-05-15 | 5.03 |
| 2026-05-14 | 4.72 |
| 2026-05-13 | 4.78 |
| 2026-05-12 | 4.99 |
| 2026-05-11 | 4.85 |
| 2026-05-08 | 4.95 |
| 2026-05-07 | 4.98 |
| 2026-05-06 | 4.93 |
| 2026-05-05 | 4.86 |
| 2026-05-04 | 4.90 |
| 2026-05-01 | 5.01 |
| 2026-04-30 | 4.86 |
| 2026-04-29 | 4.93 |
| 2026-04-28 | 5.08 |
| 2026-04-27 | 5.25 |
| 2026-04-24 | 5.27 |
| 2026-04-23 | 5.36 |
| 2026-04-22 | 5.43 |
| 2026-04-21 | 5.36 |
| 2026-04-20 | 5.53 |
| 2026-04-17 | 5.47 |
| 2026-04-16 | 5.24 |
| 2026-04-15 | 5.27 |
| 2026-04-14 | 5.39 |
| 2026-04-13 | 5.40 |
| 2026-04-10 | 5.48 |
| 2026-04-09 | 5.62 |
| 2026-04-08 | 5.63 |
| 2026-04-07 | 5.40 |
| 2026-04-06 | 5.41 |
| 2026-04-02 | 5.32 |
| 2026-04-01 | 5.34 |
| 2026-03-31 | 5.37 |
| 2026-03-30 | 5.30 |
| 2026-03-27 | 5.33 |
| 2026-03-26 | 5.65 |
| 2026-03-25 | 5.72 |
| 2026-03-24 | 5.70 |
| 2026-03-23 | 5.64 |
| 2026-03-20 | 5.73 |
| 2026-03-19 | 5.76 |
| 2026-03-18 | 5.79 |
| 2026-03-17 | 5.76 |
| 2026-03-16 | 5.68 |
| 2026-03-13 | 5.50 |
| 2026-03-12 | 5.58 |
| 2026-03-11 | 5.67 |
| 2026-03-10 | 5.80 |
| 2026-03-09 | 5.88 |
| 2026-03-06 | 5.83 |
| 2026-03-05 | 6.05 |
| 2026-03-04 | 6.24 |
| 2026-03-03 | 6.25 |
| 2026-03-02 | 6.31 |
| 2026-02-27 | 6.28 |
| 2026-02-26 | 6.36 |
| 2026-02-25 | 6.26 |
| 2026-02-24 | 6.25 |
| 2026-02-23 | 6.27 |
| 2026-02-20 | 6.25 |
| 2026-02-19 | 6.18 |
| 2026-02-18 | 6.23 |
| 2026-02-17 | 6.03 |
| 2026-02-13 | 5.99 |
| 2026-02-12 | 5.57 |
| 2026-02-11 | 6.15 |
| 2026-02-10 | 6.15 |
| 2026-02-09 | 6.33 |
| 2026-02-06 | 6.31 |
| 2026-02-05 | 6.31 |
| 2026-02-04 | 6.39 |
| 2026-02-03 | 6.46 |
| 2026-02-02 | 6.54 |
| 2026-01-30 | 6.59 |
| 2026-01-29 | 6.68 |
| 2026-01-28 | 6.62 |
| 2026-01-27 | 6.65 |
| 2026-01-26 | 6.62 |
| 2026-01-23 | 6.57 |
| 2026-01-22 | 6.67 |
| 2026-01-21 | 6.51 |
| 2026-01-20 | 6.38 |
| 2026-01-16 | 6.27 |
| 2026-01-15 | 6.25 |
| 2026-01-14 | 6.29 |
| 2026-01-13 | 6.34 |
| 2026-01-12 | 6.40 |
| 2026-01-09 | 6.08 |
| 2026-01-08 | 6.17 |
| 2026-01-07 | 6.32 |
| 2026-01-06 | 6.31 |
| 2026-01-05 | 6.10 |
| 2026-01-02 | 6.00 |
| 2025-12-31 | 5.99 |
| 2025-12-30 | 6.05 |
| 2025-12-29 | 6.09 |
| 2025-12-26 | 6.10 |
| 2025-12-24 | 6.08 |
| 2025-12-23 | 6.03 |
| 2025-12-22 | 6.08 |
| 2025-12-19 | 5.96 |
| 2025-12-18 | 5.95 |
| 2025-12-17 | 5.93 |
| 2025-12-16 | 5.99 |
| 2025-12-15 | 5.93 |
| 2025-12-12 | 6.04 |
| 2025-12-11 | 6.22 |
| 2025-12-10 | 6.09 |
| 2025-12-09 | 5.98 |
| 2025-12-08 | 5.92 |
| 2025-12-05 | 5.91 |
| 2025-12-04 | 5.89 |
| 2025-12-03 | 5.85 |
| 2025-12-02 | 5.81 |
| 2025-12-01 | 5.73 |
| 2025-11-28 | 5.73 |
| 2025-11-26 | 5.64 |
| 2025-11-25 | 5.57 |
| 2025-11-24 | 5.61 |
| 2025-11-21 | 5.43 |
| 2025-11-20 | 5.27 |
| 2025-11-19 | 5.39 |
| 2025-11-18 | 5.43 |
| 2025-11-17 | 5.28 |
| 2025-11-14 | 5.24 |
| 2025-11-13 | 5.39 |
| 2025-11-12 | 5.38 |
| 2025-11-11 | 5.24 |
| 2025-11-10 | 4.95 |
| 2025-11-07 | 4.96 |
| 2025-11-06 | 5.23 |
| 2025-11-05 | 5.35 |
| 2025-11-04 | 5.52 |
| 2025-11-03 | 5.45 |
| 2025-10-31 | 5.25 |
| 2025-10-30 | 6.15 |
| 2025-10-29 | 6.47 |
| 2025-10-28 | 6.57 |
| 2025-10-27 | 6.70 |
| 2025-10-24 | 6.68 |
| 2025-10-23 | 6.74 |
| 2025-10-22 | 6.71 |
| 2025-10-21 | 6.62 |
| 2025-10-20 | 6.49 |
| 2025-10-17 | 6.32 |
| 2025-10-16 | 6.30 |
| 2025-10-15 | 6.21 |
| 2025-10-14 | 6.28 |
| 2025-10-13 | 6.19 |
| 2025-10-10 | 6.18 |
| 2025-10-09 | 6.46 |
| 2025-10-08 | 6.43 |
| 2025-10-07 | 6.27 |
| 2025-10-06 | 6.30 |
| 2025-10-03 | 6.36 |
| 2025-10-02 | 6.31 |
| 2025-10-01 | 6.27 |
| 2025-09-30 | 6.39 |
| 2025-09-29 | 6.31 |
| 2025-09-26 | 6.37 |
| 2025-09-25 | 6.48 |
| 2025-09-24 | 6.41 |
| 2025-09-23 | 6.47 |
| 2025-09-22 | 6.60 |
| 2025-09-19 | 6.40 |
| 2025-09-18 | 7.19 |
| 2025-09-17 | 7.26 |
| 2025-09-16 | 7.27 |
| 2025-09-15 | 7.17 |
| 2025-09-12 | 7.23 |
| 2025-09-11 | 7.21 |
| 2025-09-10 | 7.21 |
| 2025-09-09 | 7.44 |
| 2025-09-08 | 7.40 |
| 2025-09-05 | 7.64 |
| 2025-09-04 | 7.67 |
| 2025-09-03 | 7.49 |
| 2025-09-02 | 7.05 |
| 2025-08-29 | 7.15 |
| 2025-08-28 | 7.13 |
| 2025-08-27 | 7.25 |
| 2025-08-26 | 7.22 |
| 2025-08-25 | 7.21 |
| 2025-08-22 | 7.81 |
| 2025-08-21 | 7.65 |
| 2025-08-20 | 7.75 |
| 2025-08-19 | 7.68 |
| 2025-08-18 | 7.67 |
| 2025-08-15 | 7.68 |
| 2025-08-14 | 7.59 |
| 2025-08-13 | 7.59 |
| 2025-08-12 | 7.61 |
| 2025-08-11 | 7.39 |
| 2025-08-08 | 7.48 |
| 2025-08-07 | 7.25 |
| 2025-08-06 | 7.25 |
| 2025-08-05 | 7.16 |
| 2025-08-04 | 7.24 |
| 2025-08-01 | 7.52 |
| 2025-07-31 | 7.67 |
| 2025-07-30 | 8.45 |
| 2025-07-29 | 8.78 |
| 2025-07-28 | 8.80 |
| 2025-07-25 | 8.74 |
| 2025-07-24 | 8.52 |
| 2025-07-23 | 8.49 |
| 2025-07-22 | 8.36 |
| 2025-07-21 | 8.26 |
| 2025-07-18 | 8.24 |
| 2025-07-17 | 8.26 |
| 2025-07-16 | 8.26 |
| 2025-07-15 | 8.33 |
| 2025-07-14 | 8.38 |
| 2025-07-11 | 8.19 |
| 2025-07-10 | 8.40 |
| 2025-07-09 | 8.34 |
| 2025-07-08 | 8.23 |
| 2025-07-07 | 8.15 |
| 2025-07-03 | 8.15 |
| 2025-07-02 | 8.21 |
| 2025-07-01 | 8.21 |
| 2025-06-30 | 8.58 |
| 2025-06-27 | 8.48 |
| 2025-06-26 | 8.35 |
| 2025-06-25 | 8.32 |
| 2025-06-24 | 8.60 |
| 2025-06-23 | 7.84 |
| 2025-06-20 | 7.86 |
| 2025-06-18 | 7.96 |
| 2025-06-17 | 8.04 |
| 2025-06-16 | 8.15 |
| 2025-06-13 | 8.05 |
| 2025-06-12 | 8.14 |
| 2025-06-11 | 8.15 |
| 2025-06-10 | 8.33 |
| 2025-06-09 | 8.42 |
| 2025-06-06 | 8.51 |
| 2025-06-05 | 8.42 |
| 2025-06-04 | 8.41 |
| 2025-06-03 | 8.53 |
| 2025-06-02 | 8.40 |
| 2025-05-30 | 8.43 |
| 2025-05-29 | 8.34 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About DexCom, Inc.
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jacob Steven Leach